Cargando…

Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays

BACKGROUND/AIMS: Cholangiocarcinoma frequently recurs even after curative resection. Expression levels of proteins such as epidermal growth factor receptor (EGFR), Snail, epithelial cadherin (E-cadherin), and interleukin-6 (IL-6) examined by immunohistochemistry have been studied as potential progno...

Descripción completa

Detalles Bibliográficos
Autores principales: Chung, Hwe Hoon, Seo, Seung Hee, Kim, Hyemin, Kim, Yuil, Kim, Dong Wuk, Lee, Kwang Hyuck, Lee, Kyu Taek, Heo, Jin Seok, Han, In Woong, Park, Seon Mee, Jang, Kee-Taek, Lee, Jong Kyun, Park, Joo Kyung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840923/
https://www.ncbi.nlm.nih.gov/pubmed/36317517
http://dx.doi.org/10.5009/gnl220044
_version_ 1784869717690810368
author Chung, Hwe Hoon
Seo, Seung Hee
Kim, Hyemin
Kim, Yuil
Kim, Dong Wuk
Lee, Kwang Hyuck
Lee, Kyu Taek
Heo, Jin Seok
Han, In Woong
Park, Seon Mee
Jang, Kee-Taek
Lee, Jong Kyun
Park, Joo Kyung
author_facet Chung, Hwe Hoon
Seo, Seung Hee
Kim, Hyemin
Kim, Yuil
Kim, Dong Wuk
Lee, Kwang Hyuck
Lee, Kyu Taek
Heo, Jin Seok
Han, In Woong
Park, Seon Mee
Jang, Kee-Taek
Lee, Jong Kyun
Park, Joo Kyung
author_sort Chung, Hwe Hoon
collection PubMed
description BACKGROUND/AIMS: Cholangiocarcinoma frequently recurs even after curative resection. Expression levels of proteins such as epidermal growth factor receptor (EGFR), Snail, epithelial cadherin (E-cadherin), and interleukin-6 (IL-6) examined by immunohistochemistry have been studied as potential prognostic factors for cholangiocarcinoma. The aim of this study was to investigate significant factors affecting the prognosis of resectable cholangiocarcinoma. METHODS: Ninety-one patients who underwent surgical resection at Samsung Medical Center for cholangiocarcinoma from 1995 to 2013 were included in this study. Expression levels of E-cadherin, Snail, IL-6, membranous EGFR, and cytoplasmic EGFR were analyzed by immunohistochemistry using tissue microarray blocks made from surgical specimens. RESULTS: Patients with high levels of membranous EGFR in tissue microarrays had significantly shorter overall survival (OS) and disease-free survival (DFS) high membranous EGFR (score 0–2) 38.0 months versus low membranous EGFR (score 3) 14.4 months (p=0.008) and high membranous EGFR (score 0–2) 23.2 months versus low membranous EGFR (score 3) 6.1 months (p=0.004), respectively. On the other hand, E-cadherin, Snail, cytoplasmic EGFR, and IL-6 did not show significant association with OS or DFS. Patients with distant metastasis had significantly higher IL-6 levels than those with locoregional recurrence (p=0.01). CONCLUSIONS: This study showed that overexpression of membranous EGFR was significantly associated with shorter OS and DFS in surgically resected bile duct cancer patients. In addition, higher IL-6 expression was a predictive marker for recurrence in cholangiocarcinoma patients with distant organ metastasis after surgical resection.
format Online
Article
Text
id pubmed-9840923
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-98409232023-01-30 Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays Chung, Hwe Hoon Seo, Seung Hee Kim, Hyemin Kim, Yuil Kim, Dong Wuk Lee, Kwang Hyuck Lee, Kyu Taek Heo, Jin Seok Han, In Woong Park, Seon Mee Jang, Kee-Taek Lee, Jong Kyun Park, Joo Kyung Gut Liver Original Article BACKGROUND/AIMS: Cholangiocarcinoma frequently recurs even after curative resection. Expression levels of proteins such as epidermal growth factor receptor (EGFR), Snail, epithelial cadherin (E-cadherin), and interleukin-6 (IL-6) examined by immunohistochemistry have been studied as potential prognostic factors for cholangiocarcinoma. The aim of this study was to investigate significant factors affecting the prognosis of resectable cholangiocarcinoma. METHODS: Ninety-one patients who underwent surgical resection at Samsung Medical Center for cholangiocarcinoma from 1995 to 2013 were included in this study. Expression levels of E-cadherin, Snail, IL-6, membranous EGFR, and cytoplasmic EGFR were analyzed by immunohistochemistry using tissue microarray blocks made from surgical specimens. RESULTS: Patients with high levels of membranous EGFR in tissue microarrays had significantly shorter overall survival (OS) and disease-free survival (DFS) high membranous EGFR (score 0–2) 38.0 months versus low membranous EGFR (score 3) 14.4 months (p=0.008) and high membranous EGFR (score 0–2) 23.2 months versus low membranous EGFR (score 3) 6.1 months (p=0.004), respectively. On the other hand, E-cadherin, Snail, cytoplasmic EGFR, and IL-6 did not show significant association with OS or DFS. Patients with distant metastasis had significantly higher IL-6 levels than those with locoregional recurrence (p=0.01). CONCLUSIONS: This study showed that overexpression of membranous EGFR was significantly associated with shorter OS and DFS in surgically resected bile duct cancer patients. In addition, higher IL-6 expression was a predictive marker for recurrence in cholangiocarcinoma patients with distant organ metastasis after surgical resection. Editorial Office of Gut and Liver 2023-01-15 2022-11-01 /pmc/articles/PMC9840923/ /pubmed/36317517 http://dx.doi.org/10.5009/gnl220044 Text en Copyright © Gut and Liver. https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Chung, Hwe Hoon
Seo, Seung Hee
Kim, Hyemin
Kim, Yuil
Kim, Dong Wuk
Lee, Kwang Hyuck
Lee, Kyu Taek
Heo, Jin Seok
Han, In Woong
Park, Seon Mee
Jang, Kee-Taek
Lee, Jong Kyun
Park, Joo Kyung
Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays
title Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays
title_full Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays
title_fullStr Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays
title_full_unstemmed Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays
title_short Postoperative Prognostic Predictors of Bile Duct Cancers: Clinical Analysis and Immunoassays of Tissue Microarrays
title_sort postoperative prognostic predictors of bile duct cancers: clinical analysis and immunoassays of tissue microarrays
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9840923/
https://www.ncbi.nlm.nih.gov/pubmed/36317517
http://dx.doi.org/10.5009/gnl220044
work_keys_str_mv AT chunghwehoon postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT seoseunghee postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT kimhyemin postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT kimyuil postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT kimdongwuk postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT leekwanghyuck postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT leekyutaek postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT heojinseok postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT haninwoong postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT parkseonmee postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT jangkeetaek postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT leejongkyun postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays
AT parkjookyung postoperativeprognosticpredictorsofbileductcancersclinicalanalysisandimmunoassaysoftissuemicroarrays